Id
|
Protein
|
PTM type
|
Site
|
Species
|
Disease
|
Celline
|
Drug
|
Regulatory
|
Score
|
Ref.
|
acc1351 |
GSK3beta |
phosphorylation |
Ser9 |
human |
Lung Cancer |
A549 |
Resveratrol |
Associated |
4.0 |
31665911
|
acc1352 |
ATF-2 |
phosphorylation |
Thr71 |
mouse |
Melanoma |
B16 |
Taxol |
Impairing |
5.0 |
18269766
|
acc1353 |
AKT |
phosphorylation |
Ser473 |
human |
Ovarian Cancer |
A2780/T |
Rg5 + docetaxel |
Associated |
4.0 |
32148406
|
acc1354 |
AKT |
phosphorylation |
Ser473 |
human |
Lung Cancer |
H1792 |
Rosiglitazone |
Associated |
4.0 |
16505118
|
acc1355 |
AKT |
phosphorylation |
Ser473 |
human |
Lung Cancer |
H1838 |
Rosiglitazone |
Associated |
4.0 |
16505118
|
acc1356 |
AKT |
phosphorylation |
Ser473 |
human |
Pancreas Cancer |
PANC-1 |
Sinapic acid |
Associated |
4.0 |
34859906
|
acc1357 |
AKT |
phosphorylation |
Ser473 |
human |
Pancreas Cancer |
SW1990 |
Sinapic acid |
Associated |
4.0 |
34859906
|
acc1358 |
AKT |
phosphorylation |
Ser473 |
human |
Hepatocellular Carcinoma |
HCC1954 |
SAIT301 |
Impairing |
5.0 |
24662823
|
acc1359 |
AR |
phosphorylation |
Ser81 |
human |
Prostate Cancer |
C4-2 |
Salinomycin |
Associated |
4.0 |
27557496
|
acc1360 |
AMPK |
phosphorylation |
Thr172 |
human |
Prostate Cancer |
C4-2 |
Salinomycin |
Associated |
4.0 |
27557496
|
acc1361 |
AMPK |
phosphorylation |
Thr183 |
human |
Prostate Cancer |
C4-2 |
Salinomycin |
Associated |
4.0 |
27557496
|
acc1362 |
Raptor |
phosphorylation |
Ser792 |
human |
Prostate Cancer |
C4-2 |
Salinomycin |
Associated |
4.0 |
27557496
|
acc1363 |
TSC-2 |
phosphorylation |
Ser1387 |
human |
Prostate Cancer |
C4-2 |
Salinomycin |
Associated |
4.0 |
27557496
|
acc1364 |
TSC-2 |
phosphorylation |
Ser939 |
human |
Prostate Cancer |
C4-2 |
Salinomycin |
Associated |
4.0 |
27557496
|
acc1365 |
TSC-2 |
phosphorylation |
Thr1462 |
human |
Prostate Cancer |
C4-2 |
Salinomycin |
Associated |
4.0 |
27557496
|
acc1366 |
p38MAPK |
phosphorylation |
Thr180 |
human |
Glioblastoma |
T98G |
SB203581 |
Impairing |
5.0 |
37185746
|
acc1367 |
p38MAPK |
phosphorylation |
Tyr182 |
human |
Glioblastoma |
T98G |
SB203581 |
Impairing |
5.0 |
37185746
|
acc1368 |
mTOR |
phosphorylation |
Ser2448 |
human |
Prostate Cancer |
DU145 |
SB225003 |
Associated |
4.0 |
29917166
|
acc1369 |
mTOR |
phosphorylation |
Ser2448 |
human |
Prostate Cancer |
PC3 |
SB225003 |
Associated |
4.0 |
29917166
|
acc1370 |
AKT2 |
phosphorylation |
Thr309 |
human |
Prostate Cancer |
LNCaP |
SB225003 |
Associated |
4.0 |
29917166
|
acc1371 |
AKT3 |
phosphorylation |
Thr305 |
human |
Prostate Cancer |
LNCaP |
SB225003 |
Associated |
4.0 |
29917166
|
acc1372 |
mTOR |
phosphorylation |
Ser2448 |
human |
Prostate Cancer |
LNCaP |
SB225003 |
Associated |
4.0 |
29917166
|
acc1373 |
AKT1 |
phosphorylation |
Thr308 |
human |
Prostate Cancer |
DU145 |
SB225003 |
Associated |
4.0 |
29917166
|
acc1374 |
AKT2 |
phosphorylation |
Thr309 |
human |
Prostate Cancer |
DU145 |
SB225003 |
Associated |
4.0 |
29917166
|
acc1375 |
AKT3 |
phosphorylation |
Thr305 |
human |
Prostate Cancer |
DU145 |
SB225003 |
Associated |
4.0 |
29917166
|
acc1376 |
AKT1 |
phosphorylation |
Thr308 |
human |
Prostate Cancer |
PC3 |
SB225003 |
Associated |
4.0 |
29917166
|
acc1377 |
AKT2 |
phosphorylation |
Thr309 |
human |
Prostate Cancer |
PC3 |
SB225003 |
Associated |
4.0 |
29917166
|
acc1378 |
AKT3 |
phosphorylation |
Thr305 |
human |
Prostate Cancer |
PC3 |
SB225003 |
Associated |
4.0 |
29917166
|
acc1379 |
AKT1 |
phosphorylation |
Thr308 |
human |
Prostate Cancer |
LNCaP |
SB225003 |
Associated |
4.0 |
29917166
|
acc1380 |
AKT |
phosphorylation |
Ser473 |
human |
Sarcoma |
EW8 |
SCH717454 |
Associated |
4.0 |
22188815
|
acc1381 |
AKT |
phosphorylation |
Ser473 |
human |
Sarcoma |
JR1 |
SCH717454 |
Associated |
4.0 |
22188815
|
acc1382 |
IN-R |
phosphorylation |
Tyr1146 |
human |
Sarcoma |
Rh18 |
SCH717454 |
Associated |
4.0 |
22188815
|
acc1383 |
IN-R |
phosphorylation |
Tyr1146 |
human |
Sarcoma |
Rh30 |
SCH717454 |
Associated |
4.0 |
22188815
|
acc1384 |
AKT |
phosphorylation |
Ser473 |
human |
Sarcoma |
Rh18 |
SCH717454 |
Associated |
4.0 |
22188815
|
acc1385 |
AKT |
phosphorylation |
Ser473 |
human |
Sarcoma |
Rh30 |
SCH717454 |
Associated |
4.0 |
22188815
|
acc1386 |
IGF-IR |
phosphorylation |
Tyr1131 |
human |
Sarcoma |
EW8 |
SCH717454 |
Associated |
4.0 |
22188815
|
acc1387 |
IGF-IR |
phosphorylation |
Tyr1131 |
human |
Sarcoma |
JR1 |
SCH717454 |
Associated |
4.0 |
22188815
|
acc1388 |
IGF-IR |
phosphorylation |
Tyr1131 |
human |
Sarcoma |
Rh18 |
SCH717454 |
Associated |
4.0 |
22188815
|
acc1389 |
IGF-IR |
phosphorylation |
Tyr1131 |
human |
Sarcoma |
Rh30 |
SCH717454 |
Associated |
4.0 |
22188815
|
acc1390 |
IN-R |
phosphorylation |
Tyr1146 |
human |
Sarcoma |
EW8 |
SCH717454 |
Associated |
4.0 |
22188815
|
acc1391 |
IN-R |
phosphorylation |
Tyr1146 |
human |
Sarcoma |
JR1 |
SCH717454 |
Associated |
4.0 |
22188815
|
acc1392 |
Bcl-2 |
phosphorylation |
Ser70 |
human |
Hepatocellular Carcinoma |
Bel7404 |
Oxaliplatin |
Impairing |
5.0 |
23279642
|
acc1393 |
AKT |
phosphorylation |
Thr308 |
human |
Prostate Cancer |
PC3 |
Selenium |
Associated |
3.0 |
16505097
|
acc1394 |
AKT |
phosphorylation |
Ser473 |
human |
Prostate Cancer |
PC3 |
Selenium |
Associated |
3.0 |
16505097
|
acc1395 |
FOXO1 |
phosphorylation |
Ser218 |
human |
Sarcoma |
ISO-HAS-B |
ATG(aPKC inhibitor) |
Associated |
4.0 |
30559384
|
acc1396 |
FOXO1 |
phosphorylation |
Ser218 |
human |
Sarcoma |
AS-M |
ATM(aPKC inhibitor) |
Associated |
4.0 |
30559384
|
acc1397 |
FOXO1 |
phosphorylation |
Ser218 |
human |
Sarcoma |
ISO-HAS-B |
ATM(aPKC inhibitor) |
Associated |
4.0 |
30559384
|
acc1398 |
FOXO1 |
phosphorylation |
Ser218 |
human |
Sarcoma |
AS-M |
ATG(aPKC inhibitor) |
Associated |
4.0 |
30559384
|
acc1399 |
AKT |
phosphorylation |
Ser473 |
human |
Leukemia |
KG-1 |
KP372-1 |
Associated |
4.0 |
16585200
|
acc1400 |
AKT |
phosphorylation |
Ser473 |
human |
Leukemia |
U937 |
KP372-1 |
Associated |
4.0 |
16585200
|